Zai Lab (ZLAB) Change in Receivables (2020 - 2026)
Zai Lab's (ZLAB) quarterly Change in Receivables came in at -$53.3 million in Q1 2026, down 509.68% year-on-year from $13.0 million in Q1 2025, and down 370.97% quarter-over-quarter from $19.7 million in Q4 2025.
Zai Lab (ZLAB) Change in Receivables (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Change in Receivables across 7 years of filings, most recently posting -$53.3 million for Q1 2026.
- Change in Receivables for Q1 2026 came in at -$53.3 million, down 509.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.6 million (down 251.38% YoY), and the FY2025 annual result was $18.9 million, down 29.82% from the prior year.
- Change in Receivables came in at -$53.3 million for Q1 2026 at Zai Lab, down from $19.7 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $36.7 million in Q4 2024 to a low of -$53.3 million in Q1 2026.
- The 5-year median for Change in Receivables is $2.9 million (2023), against an average of $491117.6.
- Across the five-year window, Change in Receivables surged 194.78% in 2023 and slumped 757.91% in 2025, its largest moves.
- Zai Lab's Change in Receivables stood at $12.2 million in 2022, then jumped by 41.67% to $17.2 million in 2023, then soared by 113.09% to $36.7 million in 2024, then sank by 46.42% to $19.7 million in 2025, then sank by 370.97% to -$53.3 million in 2026.
- The last three Change in Receivables figures came in at -$53.3 million (Q1 2026), $19.7 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -53.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.27 Mn |
| Mar 31, 2026 | -53.27 Mn |
| Dec 31, 2025 | 19.66 Mn |
| Dec 31, 2025 | 19.66 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Dec 31, 2024 | 36.69 Mn |
| Dec 31, 2024 | 36.69 Mn |
| Sep 30, 2024 | -20.55 Mn |
| Sep 30, 2024 | -20.55 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Dec 31, 2023 | 17.22 Mn |